Lv7270
4780 积分 2024-03-06 加入
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases
2天前
已完结
The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases
2天前
已完结
Progressively Enlarging Cerebellar Hematoma Concurrent with T-DM1 Treatment
2天前
已完结
Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review
2天前
已完结
Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer
2天前
已完结
Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer
2天前
已完结
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
2天前
已完结
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial
2天前
已完结
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery
2天前
已完结
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis
2天前
已完结
皖公网安备34019202002308
